Botelho H, Lopes-Pacheco M, Pinto M, Railean V, Pankonien I, Caleiro M
iScience. 2025; 28(3):111942.
PMID: 40040803
PMC: 11876911.
DOI: 10.1016/j.isci.2025.111942.
Gao X, Yeh H, Yang Z, Fan C, Jiang F, Howard R
Nat Commun. 2024; 15(1):6668.
PMID: 39107303
PMC: 11303713.
DOI: 10.1038/s41467-024-50641-1.
Young P, Levring J, Fiedorczuk K, Blanchard S, Chen J
Proc Natl Acad Sci U S A. 2024; 121(10):e2316675121.
PMID: 38422021
PMC: 10927578.
DOI: 10.1073/pnas.2316675121.
Zajac M, Lepissier A, Dreano E, Chevalier B, Hatton A, Kelly-Aubert M
Front Pharmacol. 2023; 14:1293578.
PMID: 38149052
PMC: 10750368.
DOI: 10.3389/fphar.2023.1293578.
Harris E, Easter M, Ren J, Krick S, Barnes J, Rowe S
PLoS One. 2023; 18(10):e0293367.
PMID: 37874846
PMC: 10597513.
DOI: 10.1371/journal.pone.0293367.
Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel.
Renda M, Barreca M, Borrelli A, Spano V, Montalbano A, Raimondi M
Sci Rep. 2023; 13(1):7604.
PMID: 37165082
PMC: 10172366.
DOI: 10.1038/s41598-023-34440-0.
Platelet CFTR inhibition enhances arterial thrombosis via increasing intracellular Cl concentration and activation of SGK1 signaling pathway.
Yang H, Zhang C, Hu L, Liu C, Pan N, Li M
Acta Pharmacol Sin. 2022; 43(10):2596-2608.
PMID: 35241769
PMC: 9525590.
DOI: 10.1038/s41401-022-00868-9.
Comprehensive Analysis of Combinatorial Pharmacological Treatments to Correct Nonsense Mutations in the CFTR Gene.
Venturini A, Borrelli A, Musante I, Scudieri P, Capurro V, Renda M
Int J Mol Sci. 2021; 22(21).
PMID: 34769402
PMC: 8584557.
DOI: 10.3390/ijms222111972.
Separating the contributions of SLC26A9 and CFTR to anion secretion in primary human bronchial epithelia.
Larsen M, Choi J, Wang X, Myerburg M, Frizzell R, Bertrand C
Am J Physiol Lung Cell Mol Physiol. 2021; 321(6):L1147-L1160.
PMID: 34668421
PMC: 8715023.
DOI: 10.1152/ajplung.00563.2020.
Strategies for cystic fibrosis transmembrane conductance regulator inhibition: from molecular mechanisms to treatment for secretory diarrhoeas.
De Jonge H, Ardelean M, Bijvelds M, Vergani P
FEBS Lett. 2020; 594(23):4085-4108.
PMID: 33113586
PMC: 7756540.
DOI: 10.1002/1873-3468.13971.
Phosphorylation of the Chaperone-Like HspB5 Rescues Trafficking and Function of F508del-CFTR.
Degrugillier F, Aissat A, Pruliere-Escabasse V, Bizard L, Simonneau B, Decrouy X
Int J Mol Sci. 2020; 21(14).
PMID: 32650630
PMC: 7402320.
DOI: 10.3390/ijms21144844.
Glibenclamide inhibits BK polyomavirus infection in kidney cells through CFTR blockade.
Panou M, Antoni M, Morgan E, Loundras E, Wasson C, Welberry-Smith M
Antiviral Res. 2020; 178:104778.
PMID: 32229236
PMC: 7322401.
DOI: 10.1016/j.antiviral.2020.104778.
Small Molecule Anion Carriers Correct Abnormal Airway Surface Liquid Properties in Cystic Fibrosis Airway Epithelia.
Gianotti A, Capurro V, Delpiano L, Mielczarek M, Garcia-Valverde M, Carreira-Barral I
Int J Mol Sci. 2020; 21(4).
PMID: 32098269
PMC: 7073096.
DOI: 10.3390/ijms21041488.
Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.
Amico G, Brandas C, Moran O, Baroni D
Int J Mol Sci. 2019; 20(21).
PMID: 31683989
PMC: 6862496.
DOI: 10.3390/ijms20215463.
Small molecule-facilitated anion transporters in cells for a novel therapeutic approach to cystic fibrosis.
Fiore M, Cossu C, Capurro V, Picco C, Ludovico A, Mielczarek M
Br J Pharmacol. 2019; 176(11):1764-1779.
PMID: 30825185
PMC: 6514296.
DOI: 10.1111/bph.14649.
Anion-Transport Mechanism of a Triazole-Bearing Derivative of Prodigiosine: A Candidate for Cystic Fibrosis Therapy.
Cossu C, Fiore M, Baroni D, Capurro V, Caci E, Garcia-Valverde M
Front Pharmacol. 2018; 9:852.
PMID: 30131695
PMC: 6090297.
DOI: 10.3389/fphar.2018.00852.
Structural mechanisms of CFTR function and dysfunction.
Hwang T, Yeh J, Zhang J, Yu Y, Yeh H, DeStefano S
J Gen Physiol. 2018; 150(4):539-570.
PMID: 29581173
PMC: 5881446.
DOI: 10.1085/jgp.201711946.
Small molecule anionophores promote transmembrane anion permeation matching CFTR activity.
Hernando E, Capurro V, Cossu C, Fiore M, Garcia-Valverde M, Soto-Cerrato V
Sci Rep. 2018; 8(1):2608.
PMID: 29422673
PMC: 5805763.
DOI: 10.1038/s41598-018-20708-3.
Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia.
Ahmadi S, Bozoky Z, Di Paola M, Xia S, Li C, Wong A
NPJ Genom Med. 2017; 2:12.
PMID: 28649446
PMC: 5481189.
DOI: 10.1038/s41525-017-0015-6.
Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins.
Cil O, Phuan P, Gillespie A, Lee S, Tradtrantip L, Yin J
FASEB J. 2016; 31(2):751-760.
PMID: 27871064
PMC: 5240666.
DOI: 10.1096/fj.201600891R.